Site Search

... Relations Director: “As Pennsylvania lawmakers return to the 2024 legislative session, ACS CAN calls on the Legislature to increase access to biomarker testing by voting in support of Senate Bill 954 / House Bill 1754. This legislation aims to equip countless Pennsylvanians who have received a ... diagnosis and their health care providers with critical information about their disease and how to best fight it.  “Despite the benefits of biomarker testing in improving patient outcomes and quality of life, health insurance coverage has not kept pace with innovations, coming up short ...

... toward their overall out-of-pocket maximum or deductible making cancer treatment more affordable.  Volunteers also asked the lawmakers to pass biomarker testing legislation (HB 608) that will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the right ...

... mother-daughter duo will join fellow patient advocates, medical leaders and public health allies in advancing legislation to improve access to biomarker testing, eliminate financial barriers to prostate cancer screening and end the casino loophole in the New Jersey Smoke-free Air Act. 39-year-old ... individuals,” said Julie. “Where we can’t prevent disease, we should equip patients with the best tools to fight their illness, and biomarker testing makes that possible by connecting patients to personalized treatment. But lack of insurance coverage limits who can receive the ...

Connecting Patients with the Right Treatment at the Right Time Treatment with targeted therapy often requires diagnostic testing to analyze biological samples (e.g., blood, tumor tissue) taken from a patient to identify and evaluate specific biomarkers. Research shows ... treatment for their cancer, patients can avoid treatments that will be ineffective or have more adverse side effects. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. We must work to dismantle barriers that prevent all patients from benefiting from biomarker testing and precision medicine.    Expanding Access to Patient Navigation  Navigating the healthcare system can be confusing and ...